Inhibrx Inc
General ticker "INBX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $230.0M
Inhibrx Inc does not follow the US Stock Market performance with the rate: -30.4%.
Estimated limits based on current volatility of 3.3%: low 13.72$, high 14.66$
Factors to consider:
- Company pays dividends: last record date 2024-05-30, amount 0.85$ (Y23.50%)
- Company does not operate outside North America (retrieved using AI)
- Current price 17.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [17.58$, 37.55$]
- 2024-12-30 to 2025-12-30 estimated range: [14.74$, 32.46$]
Financial Metrics affecting the INBX estimates:
- Negative: Non-GAAP EPS, $ of -5.03 <= 0.10
- Negative: Operating profit margin, % of -99.19 <= 1.03
- Negative: Operating cash flow per share per price, % of -13.75 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term INBX quotes
Long-term INBX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7.23MM | $2.19MM | $1.80MM |
| Operating Expenses | $83.80MM | $131.31MM | $221.02MM |
| Operating Income | $-76.56MM | $-129.12MM | $-219.22MM |
| Non-Operating Income | $-5.20MM | $-16.11MM | $-20.50MM |
| Interest Expense | $5.22MM | $16.11MM | $31.84MM |
| R&D Expense | $71.44MM | $110.19MM | $191.64MM |
| Income(Loss) | $-81.77MM | $-145.22MM | $-239.72MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Other Income(Loss) | $0.00MM | $0.00MM | $-1.63MM |
| Profit(Loss) | $-81.77MM | $-145.23MM | $-241.36MM |
| Stockholders Equity | $52.38MM | $58.06MM | $43.50MM |
| Inventory | $0.88MM | $0.26MM | $11.59MM |
| Assets | $150.45MM | $290.88MM | $307.89MM |
| Operating Cash Flow | $-80.32MM | $-115.30MM | $-193.31MM |
| Capital expenditure | $0.86MM | $0.69MM | $4.59MM |
| Investing Cash Flow | $-0.81MM | $-0.69MM | $-4.59MM |
| Financing Cash Flow | $83.77MM | $258.55MM | $201.96MM |
| Earnings Per Share* | $-2.15 | $-3.62 | $-5.12 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.